Recent classifications of the several pathophysiologic types of distal renal tubular acidosis (secretory, voltage dependent, and gradient) have been based on the response of acidification parameters to a series of provocative maneuvers in vivo and in vitro. A reduction in the difference in urine and blood CO2 tension during bicarbonate loading (U-B pCO2 gradient), a widely applied parameter, has been employed as an index of reduced distal nephron proton secretion. This study was designed to test the validity of the U-B pCO2 gradient in a variety of experimental models of distal renal tubular acidosis by measuring and comparing disequilibrium pH (a direct technique to detect H' secretion in situ) with the pCO2 in the papillary collecting duct of the rat in vivo during bicarbonate loading. Chronic amiloride, lithium chloride, and amphotericin-B administration, and the post-obstructed kidney models were employed. Amiloride resulted in an acidification defect which did not respond to sulfate infusion (urine pH = 6.15±0.08), and was associated with an obliteration of the acid disequilibrium pH (-0.26±0.05--0.08±0.03) and reduction in papillary pCO2 (116.9±3.2-66.9±2.5 mmHg). The defect induced by lithium administration responded to Na2SO4 (urine pH = 5.21±0.06) but was similar to amiloride with respect to the observed reduction in disequilibrium pH (-0.04±0.02) and pCO2 (90.3±3.0 mmHg). The post-obstructed kidney model was characterized by an abnormally alkaline urine pH unresponsive to sulfate (6.59±0.06) and a reduction in disequilibrium pH (+0.02±0.06) and pCO2 (77.6±3.6 mmHg). Amphotericin 
Introduction
Based on numerous observations in man and experimental animals, several distinctly different pathophysiologic mechanisms have been proposed to explain the inability to excrete a maximally acid urine in distal renal tubular acidosis (DRTA) (1) (2) (3) (4) . ' The classical view that the disorder is primarily the result of an inability to maintain a pH gradient across the distal portion of the nephron (1) was based on the observation that bicarbonate reabsorptive capacity, and presumably hydrogen ion secretion, was intact during bicarbonate loading. In addition, titratable acid excretion could be increased during phosphate infusion in these patients (5) . Therefore, it was suggested (1) that the failure of patients with classical DRTA to lower urine pH maximally during an acid challenge was the result of an inability to generate or maintain a maximum pH gradient across the distal nephron (gradient defect). However, primary impairment of the proton pump (pump or secretory defect) was suggested by the observations of Halperin and associates (6) , since patients with classical DRTA failed to generate appropriately high values for urine pCO2 during bicarbonate infusion (urine pH > 7.5). While the difference in urine and blood CO2 tension during bicarbonate loading (U-B pCO2 gradient) has been criticized on technical and physicochemical grounds (7, 8) , studies in our laboratory have demonstrated that the U-B pCO2 difference is an adequate qualitative index of distal nephron proton secretion in normal rats excreting highly alkaline urine (9) .
However, as employed widely, a reduction in the U-B PCO2 gradient has become synonymous with a reduction in distal nephron hydrogen ion secretion (2, 6) . While it has been demonstrated that the increase in papillary collecting duct (CD) pCO2 during bicarbonate loading in control rats is accompanied by an acid disequilibrium pH (pHN) in this segment (9) , a similar examination of hydrogen ion secretion in experimental models of DRTA has not been performed previously. Before the validity of U-B pCO2 can be established, therefore, direct examination of terminal nephron hydrogen ion secretion concomitant with measurement of collecting duct pCO2 in established models of DRTA appears to be necessary. The purpose of this study was to measure and compare the magnitude of the pHDq and pCO2 in the papillary CD in a wide variety of experimental models of DRTA during bicarbonate-loading in order to determine the reliability of the U-B pCO2 gradient as an index of impaired distal nephron proton secretion.
Methods
Preparation of rats for micropuncture. Studies were performed after 100 mg/kg i.p. of inactin (BYK) anesthesia (Andrew Lockwood and Associates, East Lansing, MI) on young (70-125 g) male mutant Munich-Wistar rats (Simonsen Laboratories, Gilroy, CA or Harlen Sprague-Dawley, Indianapolis, IN). All rats were allowed free access to tap water and standard rat chow until the time of anesthesia. Surgical preparation of animals for papillary micropuncture was accomplished as reported previously (9, 10) . All rats were maintained on a volumeregulated rodent ventilator (Harvard Apparatus, Inc., Millis, MA) and arterial blood gases were monitored frequently as described previously (9) . For all groups, the inspired gas content was 40% 02 (balance N2 (12) . Single-barreled electrodes were employed since previous studies in our laboratory have demonstrated that the small, variable transepithelial potential difference in this segment does not adversely affect the accuracy of the pH reading obtained in this manner (12) . Electrodes having a slope of <57 mV/pH U were not used. Calibration before and after in vivo use was as described previously (12) .
Equilibrium pH (pHQ. Equilibrium pH, defned as the pH achieved when tubule fluid is removed from the environment of the tubule in vivo and allowed to achieve chemical equilibrium, was measured with a composite probe as described in detail previously (12) . Group III A (lithium chloride, bicarbonate load) (n = 11). Lithium chloride was prepared as a 1.6-M solution and administered intraperitoneally at 4 meq/kg per d for 4 d. Rats in this group were prepared for micropuncture as in groups I and II and were infused with 300 mM NaHCO3-25 mM KCI at 1.8% BW/h for 2.0 h before initiation of micropuncture.
Group III B (lithium chloride, acid challenge) (n = 12). An additional group of rats was assessed after 4 d of lithium chloride during metabolic acidosis and after Na2SO4 infusion as in groups I and II.
Group IVA (post-obstructed kidney, bicarbonate load) (n = 7). Rats in this group underwent ligation of the lower portion of the left ureter 18.0 h before micropuncture after sodium methohexital anesthesia, intraperitoneally (0.1 ml/100 g BW) (Eli Lilly & Co., Indianapolis, IN). The ureter was approached by a small abdominal incision. After Data expressed as mean values±SEM. Numbers in parentheses equal number of rats. pH., arterial blood pH; pH., urine pH. * P < 0.001 vs.
control.
displacement of the urinary bladder, the left ureter was ligated with 1-0 silk suture and the abdominal wall and skin closed with 4-0 silk suture. After initial preparation on the next day as in the preceding groups, micropuncture was performed within 2.0 h after excising the left renal pelvis. Therefore, rats in this group were preloaded for 1.0 h with 300 mM NaHCO3 plus 25 mM KCI before release of obstruction, to insure a total of 2.0 h of bicarbonate loading as in groups I and III. Group IV B (post-obstructed kidney, acid challenge) (n = 6). An additional group of rats was assessed by the HCl-Na2SO4 acidification tests described for groups I, II, and III. Urine in this group was collected from the ureter of the left post-obstructed kidney and via the urinary bladder (right nonobstructed kidney) with PE-50 tubing into preweighed vials under water-equilibrated mineral oil.
Group VA (amphotericin-B, bicarbonate load) (n = 7). Amphotericin-B was injected intraperitoneally at 5 mg/kg BW/d for 16-20 d. This period of preparation was found to be necessary by preliminary studies in order to produce consistently an acidification defect while preventing renal failure (frequently present after 20 d in preliminary studies). Rats in this group were prepared for micropuncture as in the preceding group and infused with 300 mM NaHCO3-25 mM KC1.
Group V B (amphotericin-B, acid challenge) (n = 10). A separate group of rats was assessed for urinary acidification after 16-20 d of amphotericin-B as described above. Arterial blood and urine pH and PCO2 were determined on a blood gas analyzer (model 165, Coming Medical, Medfield, MA). Blood HCO5 was calculated by the blood gas analyzer but urine [HCO-] was calculated from the HendersonHasselbalch equation (a = 0.0309 and apparent pK corrected for ionic strength as described previously) (9) .
The results are expressed as mean values±SEM in each group.
Statistical significance was calculated using the t test for paired or unpaired data as appropriate.
Results
Systemic acid-base and whole kidney values. The acid-base status and urine pH in each group before bicarbonate loading is displayed in Table I . A mild metabolic acidosis was observed in groups II and V (E vs. C, P < 0.001) but was more severe in group II rats (amiloride). The explanation for the mild acidemia in the amphotericin-B group can be attributed to the combined effect of mild hypobicarbonatemia and an inappropriate ventilatory response. All groups had evidence of a urinary acidification defect since the initial urine pH was inappropriately alkaline (Table I) . Moreover, after infusion of 0.1 N HCO at 1.5% BW/h for 2 h, urine pH did not decrease to <5.5 in groups II-V (P < 0.001). Finally, after infusion of 3% Na2SO4, urine pH decreased below 5.5 in groups III (LiCl) and V (amphotericin-B) but not after amiloride (group II) or ureteral obstruction (group IV). The systemic acid-base and right whole kidney values observed during bicarbonate-loading are displayed in Table II . As expected, rats in each group developed metabolic alkalosis in response to bicarbonate loading. The degree of metabolic alkalosis was similar in all groups (I-V) (P > 0.05). Furthermore, the urine pH was near 8.0 in all groups. Despite the significantly lower urine pH in group 11 (7.81 vs. 7.97, P < 0.001), all rats both the base and tip (P < 0.001) (Fig. 1) . After amiloride, lithium chloride, and ureteral obstruction, however, the pHD, was obliterated as evidenced by values for in situ pH and equilibrium pH which were indistinguishable. Therefore, despite high delivery of bicarbonate to this segment, proton secretion was not of sufficient magnitude in these groups to result in the formation of H2CO3 in excess of the concentration predicted at chemical equilibrium. Conversely, however, amphotericin-B was associated with a significant acid pHDq (compared with 0.0 pH U) at both the base (-0.16±0.05, P < 0.01) and tip of the CD (-0.1 1±0.05, P < 0.05). The pCO2 data for both the BCD and TCD are displayed in Table IV and Fig. 2 . Note first that in each group the pCO2 at the tip of the papillary CD obtained by micropuncture with the pCO2 microelectrode was similar to the pCO2 in final urine from the right nonexperimental kidney measured by a conventional macroelectrode (Table II) . As noted in previous studies (9), the pCO2 increased significantly from BCD to TCD in control rats (group I) (P < 0.001). In group II (amiloride), the pCO2 at both base (46.8±2.7 mmHg) and tip CD (66.9±2.5 mmHg) was significantly lower than in controls at both sites (P < 0.001). Nevertheless, pCO2 increased significantly from BCD to TCD. In group III rats (LiCl), there was a significantly lower pCO2 at the TCD than in controls (90.3±3.0 vs. 116.9±3.2 mmHg) (P < 0.001). However, the pCO2 at the BCD (68.8±3.1 mmHg) did not differ from controls (73.2±3.7 mmHg) (P > 0.05). After ureteral obstruction, however, pCO2 was significantly lower at both the BCD (54.9±4.2) and TCD (77.6±3.6 mmHg) (P < 0.001), respectively. In contrast to the other experimental models of DRTA, amphotericin-B was associated with a papillary pCO2 which was indistinguishable from the pCO2 observed in controls (P > 0.05). Indeed, the PCO2 observed at the BCD was significantly greater than that observed in control rats (P < 0.001), so that the pCO2 profile from base to tip was no longer significant (110.4±6.8-119.8±6.4 mmHg, P > 0.05). Since the mean urine bicarbonate concentration was lower in the chronic amiloride rats (group II) than in the other groups (Table II) that the increase in urine PCO2 observed in highly alkaline urine was associated with an acid pHDq which was reduced by carbonic anhydrase infusion (9) . Although these findings support the view that the U-B pCO2 can be employed as a qualitative index of distal nephron proton secretion, a similar direct evaluation in models of deranged distal nephron acidification have not been available previously.
The present investigation was designed to measure pHDq and PCO2 in the collecting duct in several models of DRTA in the rat to determine if a reduction in U-B pCO2 is synonymous with a reduction in proton secretion. Several new findings have emerged from these studies. First, amiloride, lithium chloride, and the post-obstructed kidney, all employed commonly as models of defective distal nephron acidification, were associated uniformly with an obliteration of the acid pHEq and a reduction in pCO2 in the papillary CD. Second, amphotericin-B-treated rats with evidence of an acidification defect of the gradient type continued to maintain an acid pHN as well as the ability to generate an elevated pCO2 in the papillary CD. Therefore, these findings support utilization of the U-B pCO2 gradient to document impaired net proton secretion in the terminal nephron in voltage dependent and/ or secretory forms of distal renal tubular acidosis (RTA) and support the view that proton secretion in the gradient form of RTA is not impaired. Several types of DRTA, secretory, voltage dependent, and gradient, have been classified by both in vivo clearance techniques and by direct exposure of acidifying epithelia in vitro to drugs known to compromise acidification (2, 19) . From such in vivo-in vitro comparisons, there has not been uniformity regarding the type of mechanism proposed to explain the defect observed in experimental models. For example, in this and previous studies, chronic lithium chloride administration in rats resulted in the development of a hyperchloremic, normokalemic metabolic acidosis, an inappropriately alkaline urine pH, and a low U-B pCO2 (20, 21) . The inability to lower urine pH appropriately with spontaneous acidosis or after an acid challenge (below 5.5) is corrected by infusion of sodium sulfate in this model (21). Based on this constellation of findings, the defect induced by lithium was initially assumed to be due to a gradient defect, i.e., an excessive back-diffusion of acid as had been proposed for amphotericin-B (21). However, it was emphasized by Roscoe and associates (20) that the failure to observe an appropriate increase in U-B pCO2 after lithium was best explained by a decrease in distal nephron proton secretion (20) . Finally, studies in the turtle urinary bladder under open-circuited conditions revealed that lithium impaired proton secretion by virtue of a detrimental effect on the electrical gradient favoring H' secretion (22). Thus, it was concluded that lithium impaired urinary acidification, not as a consequence of backleak of acid but by mediating a voltage dependent impairment in proton secretion (22). It was also suggested that the normal response to sodium sulfate in the lithium model could be explained as a result of enhanced distal delivery of sodium restoring lumen-negative potential difference (2, 19, 22) . The findings in the present study during chronic lithium administration are compatible with the view that lithium impairs net acid secretion. Our finding that the acid pHN is indistinguishable from zero and is associated with a reduction in pCO2 in the papillary CD demonstrates, for the first time, that net proton secretion is impaired in a nephron segment before the first accessible portion of the papillary CD. The segment of the nephron in which lithium impairs proton secretion and the mechanism by which this occurs in vivo has not been established unequivocally. Recently, however, it has been reported that high concentrations of lithium chloride (40 mM) decreased transepithelial voltage (-11.6-0.4 mV) and bicarbonate reabsorption (10.8-4.2 pmol mm-' min-') in rabbit cortical collecting tubules perfused in vitro (23) . No effect on transepithelial voltage or bicarbonate reabsorption was observed in the medullary CD (23). It was suggested that H' secretion in the cortical (but not the medullary) CD was dependent, in part, on the negative transepithelial potential generated by outward active Na+ transport, and that this process was impaired by lithium (23). This hypothesis is also compatible with results obtained during application of LiCl to acidifying turtle bladder in vitro (22). The findings in our study, therefore, are the first to demonstrate directly a relationship between the reduction in pCO2 and disequilibrium pH in an in vivo model of voltage-dependent DRTA.
Similarly (25) . Both studies demonstrated that chronic amiloride administration was associated with the development of impaired distal acidification, an inappropriately high urine pH that did not respond to sodium sulfate infusion, and an abnormally low urine-to-blood pCO2. The amiloride model therefore differs from the lithium model in several respects. Interestingly, despite an increase in Na+ delivery to the distal nephron (as Na2SO4), the voltage-dependent defect was not corrected (25) . be independent of alterations in potassium balance (26 The classification of the defect associated with the postobstructed kidney is more problematic, however. Previous whole kidney studies have revealed that the U-B pCO2 gradient is low during bicarbonate loading, the urine pH inappropriately high during systemic acidosis, and that there is no response to sodium sulfate (29) (30) (31) . Such findings are compatible with the clearance data in the present study (Table I ). In addition, in response to phosphate administration, the U-B pCO2 failed to increase, while urinary potassium excretion was abnormally low even during sodium sulfate administration (31). These findings and the results of micropuncture studies in vivo (29) have led to the classification of the acidification defect in the post-obstructed kidney as a secretory or pump defect (2) . However, a more recent review (19) noted the similarities of the results obtained with amiloride and the post-obstructed kidney and suggested that the latter is an example of a voltagedependent defect. Unfortunately, the parameters measured in the present study do not allow the distinction between these two types of disorders, since the effect on pHN and pCO2 was identical to the results with amiloride and lithium. However, perfusion studies in vitro of tubules harvested from previously obstructed kidneys have demonstrated that the transepithelial potential difference in the cortical collecting tubule decreases from -10±2 mV to +3±4 mV, and that volume reabsorption in the presence of antidiuretic hormone is markedly impaired (32) . These findings appear to support the general formulation of a voltage-dependent defect after obstruction. Bicarbonate transport was not evaluated in the in vitro study, however, and the medullary collecting tubule has not been examined similarly. A previous micropuncture study (29) (36) (37) (38) .
The magnitude of bicarbonate secretion has been observed to increase after bicarbonate loading in vivo (38) . Unfortunately, we are unable to determine with papillary micropuncture techniques if bicarbonate secretion could be occurring in this model beyond the late distal tubule before the base papillary collecting tubule. Since the concentration of bicarbonate in the collecting duct in the present study is -200 mM, the concentration gradient required for passive secretion seems unlikely. The effect of amphotericin-B on cortical or medullary collecting tubule bicarbonate transport has not been examined in vitro. Nevertheless, it is clear from the present study that the U-B pCO2 technique as applied in clearance studies indicates intact proton secretion in models of gradient or backleak distal RTA. Therefore, an inappropriately alkaline urine pH after an acid challenge which is corrected by Na2SO4 infusion (<5.5 U) must be coupled with the demonstration of a normal U-B pCO2 to reliably characterize this type of DRTA. Interestingly, in this regard, the observation by Halperin and colleagues (6) that the U-B pCO2 is often decreased in classical distal RTA in man suggests that this disorder is not due to a gradient defect, as first proposed, but a result of a voltage or secretory defect. Nevertheless, we consider this view somewhat speculative until a suitable experimental model of classical distal RTA can be developed and examined in more detail.
In summary, we have demonstrated that amiloride, lithium, and the post-obstructed kidney impair urinary acidification and net H' secretion in the terminal nephron. The U-B pCO2
gradient, as applied in whole kidney studies, appears to demonstrate the defect in distal nephron proton secretion reliably. Amphotericin-B, however, impairs the ability to maintain a pH gradient in the collecting tubule, but the ability to increase urine pCO2 during bicarbonate loading remains intact. While the explanation for this latter observation is not entirely clear, the findings suggest that the U-B pCO2 gradient must be combined with other dynamic tests of urinary acidification in order to characterize reliably the acidification defect in the gradient form of DRTA.
